FindMyRecallSubscribe
Class III: unlikely to cause harmOngoing

Alembic Pharmaceuticals Fesoterodine Fumarate Recall

Fesoterodine Fumarate, Extended-release Tablets, 8 mg, 30 Tablets, Rx only, Manufacture…

Alembic Pharmaceuticals Limited

Risk level
Class III
Reported by FDA
Jan 14, 2026
Recall ID
D-0248-2026
Check your lot numberHow we source this data

Summary

Alembic Pharmaceuticals recalled Fesoterodine Fumarate starting Dec 16, 2025. The FDA classified it as Class III (unlikely to cause harm) and published enforcement report D-0248-2026 on Jan 14, 2026. Reason: Failed Impurities/Degradation Specifications: Due to levels of 'Diester Impurity' exceeding the specification limit. Status: Ongoing.

Why it was recalled

Failed Impurities/Degradation Specifications: Due to levels of 'Diester Impurity' exceeding the specification limit.

Product description

Fesoterodine Fumarate, Extended-release Tablets, 8 mg, 30 Tablets, Rx only, Manufactured by: Alembic Pharmaceuticals Limited, Panelav 389350, Gujarat, India, Manufactured for: Alembic Pharmaceuticals, Inc., Bedminster, NJ 07921, USA, NDC 62332-176-30

Lot numbers, UPCs & expiration codes

Lot# 2405003360, Exp Date: Jan 31, 2026

Where it was sold

US Nationwide and PR.

What to do if you have this product

  • Compare the lot number and expiration date on your package with the codes above.
  • Don't stop taking a prescription medicine on your own. Call your pharmacist or doctor; they can confirm whether your supply is affected and arrange a replacement.
  • If you have symptoms you think are related, contact your doctor. In an emergency call 911.
  • Report side effects to FDA MedWatch at 1-800-FDA-1088.

Recall details

Recall number
D-0248-2026
Classification
Class III
Status
Ongoing
Recall initiated
Dec 16, 2025
FDA report date
Jan 14, 2026
Recall type
Voluntary: Firm initiated
Recalling firm
Alembic Pharmaceuticals Limited

Original FDA data

Every field from FDA enforcement report D-0248-2026, exactly as published.

Show all FDA fields
City
Panchmahal
Status
Ongoing
Country
India
Event ID
98119
Address
Formulation Division, Village Panelav, P.O. Tajpura, Near Baska, Taluka Halol
Code information
Lot# 2405003360, Exp Date: Jan 31, 2026
Report date
Jan 14, 2026
Product type
Drugs
Recall number
D-0248-2026
Classification
Class III
Recalling firm
Alembic Pharmaceuticals Limited
Reason for recall
Failed Impurities/Degradation Specifications: Due to levels of 'Diester Impurity' exceeding the specification limit.
Voluntary / mandated
Voluntary: Firm initiated
Product description
Fesoterodine Fumarate, Extended-release Tablets, 8 mg, 30 Tablets, Rx only, Manufactured by: Alembic Pharmaceuticals Limited, Panelav 389350, Gujarat, India, Manufactured for: Alembic Pharmaceuticals, Inc., Bedminster, NJ 07921, USA, NDC 62332-176-30
Distribution pattern
US Nationwide and PR.
Recall initiation date
Dec 16, 2025
Center classification date
Jan 2, 2026

How we source this data

Source: U.S. Food and Drug Administration enforcement report D-0248-2026, published Jan 14, 2026. View the source record (openFDA) · FDA enforcement reports

Last checked against FDA data: . Content last changed: .

FindMyRecall is an independent service and is not affiliated with or endorsed by the FDA. This page simplifies the official record; the FDA or manufacturer notice is authoritative, so follow its instructions. Medication information here is not individualized medical advice.

How we source and update recall data · Report incorrect information

Other recent drug recalls